Setting the Bar Higher: Think You Know DHE? Think Again.

Industry-Sponsored Event

Sponsored by Impel Pharmaceuticals

Not Eligible for CME Credits Sara E. Sacco, MD Carolinas Headache Clinic Deborah I. Friedman, MD, MPH, FAHS University of Texas Southwestern

You may think you know this highly effective molecule, but there’s so much more to know. Today, innovative nasal delivery revolutionizes the DHE story with well-established safety and tolerability. While new medications have changed the migraine treatment landscape, many patients will tell you that these meds regularly fall short of delivering complete relief. Trudhesa delivered via POD gives patients DHE relief on demand.

Objectives:

• To challenge perceptions about DHE’s history, pharmacology, safety profile

• To present the scientific and clinical rationale for the upper nasal space as a target for drug delivery

• To make the case for a novel and accessible patient-administered intranasal delivery system of DHE